Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG

In a Clinical Laboratory Improvement Amendments laboratory setting, we evaluated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG detection with 4 lateral flow immunoassays [LFIAs; 2 iterations from BTNX Inc. (n = 457) and 1 each from ACON Laboratories (n = 200) and SD BIOSENSOR (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: McAulay, Kathrine, Bryan, Andrew, Greninger, Alexander L., Grill, Francisca, Lake, Douglas, Kaleta, Erin J., Grys, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395943/
https://www.ncbi.nlm.nih.gov/pubmed/32947206
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395943/
https://www.ncbi.nlm.nih.gov/pubmed/32947206
http://dx.doi.org/10.1016/j.diagmicrobio.2020.115161

Ejemplares similares